Berberine Chloride Hydrate

References

• Berberine Induces Mitophagy through Adenosine Monophosphate-Activated Protein Kinase and Ameliorates Mitochondrial Dysfunction in PINK1 Knockout Mouse Embryonic Fibroblasts
  • J.-H. Um, K.-M. Lee, Y.-Y. Kim, D.-Y. Lee, E. Kim, D.-H. Kim, J. Yun, Int. J. Mol. Sci. 2024, 25, 219.
• Berberine Rescues D-Ribose-Induced Alzheimer‘s Pathology via Promoting Mitophagy
  • C. Wang, Q. Zou, Y. Pu, Z. Cai, Y. Tang, Int. J. Mol. Sci. 2023, 24, 5896.
• Berberine suppresses influenza virus-triggered NLRP3 inflammasome activation in macrophages by inducing mitophagy and decreasing mitochondrial ROS
  • H. Liu et al., J. Leukoc. Biol. 2020,108, 253.
• Berberine protects steatotic donor undergoing liver transplantation via inhibiting endoplasmic reticulum stress-mediated reticulophagy
  • N. Zhang, M. Sheng, M. Wu, X. Zhang, Y. Ding, Y. Lin, W. Yu, S. Wang, H. Du, Exp. Biol. Med. 2019, 244, 1695.
• Berberine Ameliorates High Glucose-Induced Cardiomyocyte Injury via AMPK Signaling Activation to Stimulate Mitochondrial Biogenesis and Restore Autophagic Flux
  • W. Hang et al., Front. Pharmacol. 2018, 9, 1121.

References

• Berberine Promotes Osteoblast Differentiation by Runx2 Activation With p38 MAPK　
  • H. W. Lee, J. H. Suh, H.-N. Kim, A. Y. Kim, S. Y. Park, C. S. Shin, J.-Y. Choi, J. B. Kim, J. Bone Miner. Res. 2008, 23, 1227.
• Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-κB and Akt pathways
  • J.-P. Hu, K. Nishishita, E. Sakai, H. Yoshida, Y. Kato, T. Tsukuba, K. Okamoto, Eur. J. Pharmacol. 2008, 580, 70.

References

• 1) Identification of natural compounds which inhibit biofilm formation in clinical isolates of Klebsiella pneumoniae
• H. Magesh, A. Kumar, A. Alam, Priyam, U. Sekar, V. N. Sumantran, R. Vaidyanathan, Indian J. Exp. Biol. 2013, 51, 764.
• 2) Effectiveness of efflux pump inhibitors as biofilm disruptors and resistance breakers in gram-negative (ESKAPEE) bacteria
• A. Reza, J. M. Sutton, K. M. Rahman, Antibiotics 2019, 8, 229

References

• 1)Berberine: a potential phytochemical with multispectrum therapeutic activities (a review)
  • P. R. Vuddanda, S. Chakraborty, S. Singh, Expert Opin. Invest. Drugs 2010, 19, 1297.
• 2)Berberine and Coptidis Rhizoma as novel antineoplastic agents: A review of traditional use and biomedical investigations (a review)
  • J. Tang, Y. Feng, S. Tsao, N. Wang, R. Curtain, Y. Wang, J. Ethnopharmacol. 2009, 126, 5.
• 3)The anti-inflammatory potential of berberine in vitro and in vivo
  • C.-L. Kuo, C.-W. Chi, T.-Y. Liu, Cancer Lett. 2004, 203, 127.
• 4)Cardiovascular actions of berberine (a review)
  • Chi-Wai Lau, Xiao-Qiang Yao, Zhen-Yu Chen, Wing-Hung Ko and Yu Huang, Cardiovasc. Drug Rev. 2001, 19, 234.
• 5)Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states
  • Y. S. Lee, W. S. Kim, K. H. Kim, M. J. Yoon, H. J. Cho, Y. Shen, J.-M. Ye, C. H. Lee, W. K. Oh, C. T. Kim, C. Hohnen-Behrens, A. Gosby, E. W. Kraegen, D E. James, J. B. Kim, Diabetes 2006, 55, 2256.
• 6)Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: A mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action
  • N. Turner, J.-Y. Li, A. Gosby, S. W. C. To, Z. Cheng, H. Miyoshi, M. M. Taketo, G. J. Cooney, E. W. Kraegen, D. E. James, L.-H. Hu, J. Li, J.-M. Ye, Diabetes 2008, 57, 1414.
• 7)Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins
  • W. Kong, J. Wei, P. Abidi, M. Lin, S. Inaba, C. Li, Y. Wang, Z. Wang, S. Si, H. Pan, S. Wang, J. Wu, Y. Wang, Z. Li, J. Liu, J.-D. Jiang, Nat. Med. 2004, 10, 1344.
• 8)Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders (a review)
  • S. K. Kulkarni, A. Dhir, Phytother. Res. 2010, 24, 317.